These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 20581898
1. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease. Bryant DL, Miles CJ, Gearry RB. N Z Med J; 2010 Apr 30; 123(1313):74-6. PubMed ID: 20581898 [Abstract] [Full Text] [Related]
2. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease]. López-Martín C, de la Fuente-Fernández E, Corbatón P, Sánchez MC, Gisbert JP. Gastroenterol Hepatol; 2011 Jan 30; 34(1):16-9. PubMed ID: 21168244 [Abstract] [Full Text] [Related]
3. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. Duvoux C, Kracht M, Lang P, Vernant JP, Zafrani ES, Dhumeaux D. Gastroenterol Clin Biol; 1991 Jan 30; 15(12):968-73. PubMed ID: 1783253 [Abstract] [Full Text] [Related]
4. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease. Calabrese E, Hanauer SB. J Crohns Colitis; 2011 Feb 30; 5(1):48-53. PubMed ID: 21272804 [Abstract] [Full Text] [Related]
7. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature. Dooremont D, Decaestecker J, De Wulf D, Ghillebert G, Van Vlierberghe H, Van Dorpe J, Baert F. Acta Gastroenterol Belg; 2013 Sep 30; 76(3):342-6. PubMed ID: 24261031 [Abstract] [Full Text] [Related]
8. Azathioprine induced nodular regenerative hyperplasia in IBD patients. Daniel F, Cadranel JF, Seksik P, Cazier A, Duong Van Huyen JP, Ziol M, Coutarel P, Loison P, Jian R, Marteau P. Gastroenterol Clin Biol; 2005 May 30; 29(5):600-3. PubMed ID: 15980758 [Abstract] [Full Text] [Related]
9. Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects? Gilissen LP, Derijks LJ, Driessen A, Bos LP, Hooymans PM, Stockbrügger RW, Engels LG. Dig Liver Dis; 2007 Feb 30; 39(2):156-9. PubMed ID: 17188950 [Abstract] [Full Text] [Related]
11. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Boureille A, Duclos B, Seksik P, Mary JY, Colombel JF. Gut; 2007 Oct 30; 56(10):1404-9. PubMed ID: 17504943 [Abstract] [Full Text] [Related]
12. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease]. Cohen-Ezra O, Avni Y, Morgenstern S, Ben-Ari Z. Harefuah; 2012 Dec 30; 151(12):675-8, 721. PubMed ID: 23330258 [Abstract] [Full Text] [Related]